Verona Pharma plc (VRNA)

Verona Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	336.04	271.77	227.83	148.38	187.99	30.43
Short-Term Investments	-	-	-	-	-	10.38
Cash & Short-Term Investments	336.04	271.77	227.83	148.38	187.99	40.81
Cash Growth	30.57%	19.29%	53.54%	-21.07%	360.66%	-36.93%
Other Receivables	5.59	10.95	9.28	15.58	8.26	9.81
Receivables	12.49	10.95	9.28	15.58	8.26	9.81
Prepaid Expenses	7.96	3.62	2.5	4.04	4.54	1.66
Other Current Assets	3.44	3.37	3.39	2.06	1.72	2.02
Total Current Assets	364.25	289.71	243	170.06	202.5	54.3
Property, Plant & Equipment	2.02	2.87	0.93	0.98	1.16	1.35
Long-Term Investments	15	15	15	15	-	-
Goodwill	0.55	0.55	0.55	0.55	0.55	0.59
Total Assets	381.82	308.12	259.47	186.59	204.21	56.23
Accounts Payable	6.83	3.49	2.91	10.04	0.18	1.93
Accrued Expenses	18.31	3.59	13.75	22.26	10.86	8.97
Current Portion of Leases	0.95	1.18	0.68	0.65	0.8	0.61
Current Income Taxes Payable	1.01	-	0.28	0.15	-	-
Other Current Liabilities	0.84	0.44	1.41	0.33	2.36	1.33
Total Current Liabilities	27.95	8.69	19.03	33.42	14.2	12.84
Long-Term Debt	120.01	48.37	9.77	4.87	4.64	-
Long-Term Leases	1.35	1.78	0.21	0.29	0.51	0.65
Other Long-Term Liabilities	102.02	-	-	-	-	-
Total Liabilities	251.33	58.84	29	38.58	19.35	13.49
Common Stock	42.77	42.77	40.53	31.86	31.79	7.27
Additional Paid-In Capital	621.63	601.06	529.19	385.07	366.41	179.54
Retained Earnings	-528.48	-388.43	-333.1	-263.72	-207.05	-141.78
Treasury Stock	-0.83	-1.52	-1.55	-0.6	-1.7	-
Comprehensive Income & Other	-4.6	-4.6	-4.6	-4.6	-4.6	-2.28
Shareholders' Equity	130.49	249.28	230.47	148.01	184.85	42.74
Total Liabilities & Equity	381.82	308.12	259.47	186.59	204.21	56.23
Total Debt	122.31	51.33	10.65	5.81	5.95	1.26
Net Cash (Debt)	213.73	220.44	217.18	142.57	182.04	39.55
Net Cash Growth	-9.84%	1.50%	52.33%	-21.68%	360.33%	-38.88%
Net Cash Per Share	2.64	2.78	3.28	2.41	5.54	3.00
Filing Date Shares Outstanding	81.83	86.83	78.99	60.37	57.93	13.17
Total Common Shares Outstanding	81.83	80.44	75.79	60.01	57.91	13.17
Working Capital	336.3	281.02	223.97	136.64	188.3	41.46
Book Value Per Share	1.59	3.10	3.04	2.47	3.19	3.25
Tangible Book Value	129.95	248.74	229.92	147.46	184.31	42.16
Tangible Book Value Per Share	1.59	3.09	3.03	2.46	3.18	3.20

Source: S&P Capital IQ. Standard template. Financial Sources.